Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.
RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.
2 Disclosed Funding Rounds $20,000,000
0 Participating Investments
Therapeutics, Biotechnology, Life Science
Scribe Therapeutics is a biotech company that develops and engineers new therepeutics based on CRISPR.
Alameda,
California,
United States,
North America
(US)
Organizations in Alameda in Therapeutics,
Organizations in Alameda in Biotechnology,
Organizations in Alameda in Life Science,
Organizations in California in Therapeutics,
Organizations in California in Biotechnology,
Organizations in California in Life Science,
Organizations in United States in Therapeutics,
Organizations in United States in Biotechnology,
Organizations in United States in Life Science,
Organizations in North America in Therapeutics,
Organizations in North America in Biotechnology,
Organizations in North America in Life Science
Investors in Alameda in Therapeutics,
Investors in Alameda in Biotechnology,
Investors in Alameda in Life Science,
Investors in California in Therapeutics,
Investors in California in Biotechnology,
Investors in California in Life Science,
Investors in United States in Therapeutics,
Investors in United States in Biotechnology,
Investors in United States in Life Science,
Investors in North America in Therapeutics,
Investors in North America in Biotechnology,
Investors in North America in Life Science
West Coast (0 Investors) (0 Startups), Western US (0 Investors) (0 Startups), San Francisco Bay Area (0 Investors) (0 Startups)
Founded date 01, 2018
Founders
Brett Staahl,
David F. Savage,
Jennifer Doudna,
Benjamin Oakes
Operating Status Active
Funding Stage Early Stage Venture
Last Funding Type Series A
Company Type For Profit
Contact
Hunter Lookup
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR. The company’s first technology, called X-Editing (XE) molecules, are highly engineered CRISPR enzymes that provide combined aspects of greater efficacy, specificity, and deliverability than currently available CRISPR genome editing technology. It also a long-term, engineering approach that can help establish CRISPR-based therapies as a new standard of clinical care and expand access to groundbreaking treatments that will impact millions of lives. Scribe Therapeutics is overcoming the limitations of current genome editing technologies by developing custom-engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company built for exceptional specificity within the genome – enabling therapeutic precision and allele-specific targeting. Scribe Therapeutics was founded in 2018 and is headquartered in Alameda, CA, USA.
Date | Round | Raised | Lead |
---|---|---|---|
March, 31, 2021 | Series B | $100,000,000 |
![]() |
January, 01, 2018 | Series A | $20,000,000 |
![]() |
Scribe Therapeutics Investors (10)
Investor | Lead? | Round | Participating Raise | Date | Partners | ||
---|---|---|---|---|---|---|---|
![]() |
|
Avoro Capital Advisors | Yes | Series B | $100,000,000 | March, 31, 2021 | ------- |
![]() |
|
Wellington Management | No | Series B | $100,000,000 | March, 31, 2021 | ------- |
![]() |
![]() |
T. Rowe Price | No | Series B | $100,000,000 | March, 31, 2021 | ------- |
![]() |
![]() |
RA Capital Management | No | Series B | $100,000,000 | March, 31, 2021 | ------- |
![]() |
![]() |
Perceptive Advisors | No | Series B | $100,000,000 | March, 31, 2021 | ------- |
![]() |
![]() |
OrbiMed | No | Series B | $100,000,000 | March, 31, 2021 | ------- |
![]() |
![]() |
Menlo Ventures | No | Series B | $100,000,000 | March, 31, 2021 | ------- |
![]() |
Avoro Ventures | Yes | Series B | $100,000,000 | March, 31, 2021 | ------- | |
![]() |
|
Andreessen Horowitz | No | Series B | $100,000,000 | March, 31, 2021 | ------- |
![]() |
|
Andreessen Horowitz | Yes | Series A | $20,000,000 | January, 01, 2018 | ------- |
Scribe Therapeutics in the News
Related Companies All
Latest fundings in these markets All
New related Companies All
Also in Organization All




Similar People in Market All
Recommended
Recent Searches All
Latest Viewed All















